EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 21 (2014) Parasite, 21 (2014) 63 References
Issue
Parasite
Volume 21, 2014
Innovation for the Management of Echinococcosis. Invited editors: Dominique A. Vuitton, Laurence Millon, Bruno Gottstein and Patrick Giraudoux
Article Number 63
Number of page(s) 10
DOI https://doi.org/10.1051/parasite/2014063
Published online 28 November 2014
  1. Ammann RW, Renner EC, Gottstein B, Grimm F, Eckert J, Renner EL, Swiss Echinococcosis Study Group. 2004. Immunosurveillance of alveolar echinococcosis by specific humoral and cellular immune tests: prospective long-term analysis of the Swiss chemotherapy trial (1976–2001). Journal of Hepatology, 41, 551–559. [CrossRef] [PubMed] [Google Scholar]
  2. Azizi A, Blagosklonov O, Ahmed L, Berthet L, Vuitton DA, Bresson-Hadni S, Delabrousse E. 2014. Alveolar echinococcosis: correlation between MRI aspect of hepatic lesions and the metabolic activity visualized in FDG-PET/CT. In: Proceedings of the International Symposium “Innovation for the Management of Echinococcosis”, Besançon, March 27–29, 2014, p. 10. [Google Scholar]
  3. Becce F, Pomoni A, Uldry E, Halkic N, Yan P, Meuli R, Schmidt S. 2014. Alveolar echinococcosis of the liver: diffusion-weighted MRI findings and potential role in lesion characterisation. European Journal of Radiology, 83, 625–631. [CrossRef] [PubMed] [Google Scholar]
  4. Ben Nouir N, Gianinazzi C, Gorcii M, Müller N, Nouri A, Babba H, Gottstein B. 2009. Assessment of Echinococcus granulosus somatic protoscolex antigens for serological follow-up of young patients surgically treated for cystic echinococcosis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 103, 355–364. [CrossRef] [PubMed] [Google Scholar]
  5. Bresson-Hadni S, Blagosklonov O, Knapp J, Grenouillet F, Sako Y, Delabrousse E, Brientini MP, Richou C, Minello A, Antonino AT, Ito A, Mantion GA, Vuitton DA. 2011. Should possible recurrence of disease contraindicate liver transplantation in patients with end-stage alveolar echinococcosis? A 20-year followup study. Liver Transplantation, 17, 855–865. [CrossRef] [Google Scholar]
  6. Brunetti E, Kern P, Vuitton DA, Writing Panel for the WHO-IWGE. 2010. Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Tropica, 114, 1–16. [CrossRef] [PubMed] [Google Scholar]
  7. Bruzinskaite R, Marcinkute A, Strupas K, Sokolovas V, Deplazes P, Mathis A, Eddi C, Sarkūnas M. 2007. Alveolar Echinococcosis, Lithuania. Emerging Infectious Diseases, 13, 1618–1619. [CrossRef] [PubMed] [Google Scholar]
  8. Caoduro C, Porot C, Vuitton DA, Bresson-Hadni S, Grenouillet F, Richou C, Boulahdour H, Blagosklonov O. 2013. The role of delayed 18F-FDG PET imaging in the follow-up of patients with alveolar echinococcosis. Journal of Nuclear Medicine, 54, 358–363. [CrossRef] [Google Scholar]
  9. Chauchet A, Grenouillet F, Knapp J, Richou C, Delabrousse E, Dentan C, Capelle S, Di Martino V, Deconinck E, Blagosklonov O, Vuitton DA, Bresson-Handi S. 2013. Emergence of a new opportunistic infection in Europe: hepatic alveolar echinococcosis. Fifty case-report. Journal of Hepatology, 58 (Suppl 11), S381. [CrossRef] [Google Scholar]
  10. Craig PS. 1986. Detection of specific circulating antigen, immune complexes and antibodies in human hydatidosis from Turkana (Kenya) and Great Britain, by enzyme-immunoassay. Parasite Immunology, 8, 171–188. [CrossRef] [PubMed] [Google Scholar]
  11. Del Carpio M, Mercapide CH, Salvitti JC, Uchiumi L, Sustercic J, Panomarenko H, Moguilensky J, Herrero E, Talmon G, Volpe M, Araya D, Mujica G, Calabro A, Mancini S, Chiosso C, Labanchi JL, Saad R, Goblirsch S, Brunetti E, Larrieu E. 2012. Early diagnosis, treatment and follow-up of cystic echinococcosis in remote rural areas in Patagonia: impact of ultrasound training of non-specialists. PLoS Neglected Tropical Diseases, 6(1), e1444. [CrossRef] [PubMed] [Google Scholar]
  12. Diebold Berger S, Khan H, Gottstein B, Puget E, Frossard JL, Remadi S. 1997. Cytologic diagnosis of isolated pancreatic alveolar hydatid disease with immunologic and PCR analyses – a case report. Acta Cytologica, 41, 1381–1386. [CrossRef] [PubMed] [Google Scholar]
  13. Emery I, Leclerc C, Sengphommachanh K, Vuitton DA, Liance M. 1998. In vivo treatment with recombinant IL-12 protects C57BL/6J mice against secondary alveolar echinococcosis. Parasite Immunology, 20, 81–91. [CrossRef] [PubMed] [Google Scholar]
  14. Ferragut G, Ljungström I, Nieto A. 1998. Relevance of circulating antigen detection to follow-up experimental and human cystic hydatid infections. Parasite Immunology, 20, 541–549. [CrossRef] [PubMed] [Google Scholar]
  15. Frider B, Moguilensky J, Salvitti JC, Odriozola M, Cantoni G, Larrieu E. 2001. Epidemiological surveillance of human hydatidosis by means of ultrasonography: its contribution to the evaluation of control programs. Acta Tropica, 79, 219–223. [CrossRef] [PubMed] [Google Scholar]
  16. Gesy K, Hill JE, Schwantje H, Liccioli S, Jenkins EJ. 2013. Establishment of a European-type strain of Echinococcus multilocularis in Canadian wildlife. Parasitology, 140, 1133–1137. [CrossRef] [PubMed] [Google Scholar]
  17. Gocan H, Surd A, Dobrescu I, Pop E. 2010. The role of ultrasonography in Albendazole treatment of hydatid liver cyst monitoring in children – three case reports. Medical Ultrasonography Journal, 12, 340–344. [Google Scholar]
  18. Godot V, Harraga S, Beurton I, Deschaseaux M, Sarciron E, Gottstein B, Vuitton DA. 2000. Resistance/susceptibility to Echinococcus multilocularis infection and cytokine profile in humans. I. Comparison of patients with progressive and abortive lesions. Clinical and Experimental Immunology, 121, 484–490. [CrossRef] [PubMed] [Google Scholar]
  19. Godot V, Harraga S, Beurton I, Tiberghien P, Sarciron E, Gottstein B, Vuitton DA. 2000. Resistance/susceptibility to Echinococcus multilocularis infection and cytokine profile in humans. II. Influence of the HLA B8, DR3, DQ2 haplotype. Clinical and Experimental Immunology, 121, 491–498. [CrossRef] [PubMed] [Google Scholar]
  20. Godot V, Harraga S, Podoprigora G, Liance M, Bardonnet K, Vuitton DA. 2003. IFN alpha-2a protects mice against a helminth infection of the liver and modulates immune responses. Gastroenterology, 124, 1441–1450. [CrossRef] [PubMed] [Google Scholar]
  21. Gottstein B. 1984. An immunoassay for the detection of circulating antigens in human echinococcosis. American Journal of Tropical Medicine and Hygiene, 33, 1185–1191. [Google Scholar]
  22. Harraga S, Godot V, Bresson-Hadni S, Pater C, Beurton I, Bartholomot B, Vuitton DA. 1999. Clinical efficacy of and switch from T helper 2 to T helper 1 cytokine profile after interferon alpha2a monotherapy for human echinococcosis. Clinical Infectious Diseases, 29, 205–206. [CrossRef] [Google Scholar]
  23. Hernández-González A, Muro A, Barrera I, Ramos G, Orduña A, Siles-Lucas M. 2008. Usefulness of Four different Echinococcus granulosus recombinant antigens for serodiagnosis of unilocular hydatid disease (UHD) and postsurgical follow-up of patients treated for UHD. Clinical Vaccine Immunology, 15, 147–153. [CrossRef] [Google Scholar]
  24. Hosch W, Stojkovic M, Jänisch T, Kauffmann GW, Junghanss T. 2007. The role of calcification for staging cystic echinococcosis (CE). European Radiology, 17, 2538–2545. [CrossRef] [PubMed] [Google Scholar]
  25. Huang X, Grüner B, Lechner CJ, Kern P, Soboslay PT. 2014. Distinctive cytokine, chemokine, and antibody responses in Echinococcus multilocularis-infected patients with cured, stable, or progressive disease. Med Microbiological Immunology, 203, 185–193. [CrossRef] [Google Scholar]
  26. Ito A, Craig PS. 2003. Immunodiagnostic and molecular approaches for the detection of taeniid cestode infections. Trends in Parasitology, 19, 377–381. [CrossRef] [PubMed] [Google Scholar]
  27. Jorgensen P, van der Heiden M, Kern P, Schöneberg I, Krause G, Alpers K. 2008. Underreporting of human alveolar echinococcosis, Germany. Emerging Infectious Diseases, 14, 935–937. [CrossRef] [PubMed] [Google Scholar]
  28. Kern P. 2010. Clinical features and treatment of alveolar echinococcosis. Current Opinion in Infectious Diseases, 23, 505–512. [CrossRef] [PubMed] [Google Scholar]
  29. Kocherscheidt L, Flakowski AK, Grüner B, Hamm DM, Dietz K, Kern P, Soboslay PT. 2008. Echinococcus multilocularis: inflammatory and regulatory chemokine responses in patients with progressive, stable and cured alveolar echinococcosis. Experimental Parasitology, 119, 467–474. [CrossRef] [PubMed] [Google Scholar]
  30. Larrieu E, Del Carpio M, Mercapide CH, Salvitti JC, Sustercic J, Moguilensky J, Panomarenko H, Uchiumi L, Herrero E, Talmon G, Volpe M, Araya D, Mujica G, Mancini S, Labanchi JL, Odriozola M. 2011. Programme for ultrasound diagnoses and treatment with albendazole of cystic echinococcosis in asymptomatic carriers: 10 years of follow-up of cases. Acta Tropica, 117, 1–5. [CrossRef] [PubMed] [Google Scholar]
  31. Lechner C, Grüner B, Huang X, Hoffmann WH, Kern P, Soboslay PT. 2012. Parasite-specific IL-17-type cytokine responses and soluble IL-17 receptor levels in alveolar echinococcosis patients. Clinical and Developmental Immunology, Article ID: 735342. [Google Scholar]
  32. Li J, Zhang WB, Lin RY, Wang H, Li L, Wang JH, McManus DP, Wen H. 2014. Circulating Antigen B in Cystic Echinococcosis patients antibody-negative against hydatid cyst fluid antigens. Parasite (in press). [Google Scholar]
  33. Li T, Ito A, Pengcuo R, Sako Y, Chen X, Qiu D, Xiao N, Craig PS. 2011. Post-treatment follow-up study of abdominal cystic echinococcosis in Tibetan communities of Northwest Sichuan province, China. PLoS Neglected Tropical Diseases, 5, e1364. [CrossRef] [PubMed] [Google Scholar]
  34. Li T, Ito A, Pengcuo R, Sako Y, Chen X, Qiu D, Xiao N, Craig PS. 2011. Post-treatment follow-up study of abdominal cystic echinococcosis in Tibetan communities of northwest Sichuan Province, China. PloS Neglected Tropical Diseases, 5(10), e1364. [Google Scholar]
  35. Liu YH, Wang XG, Gao JS, Qingyao Y, Horton J. 2009. Continuous albendazole therapy in alveolar echinococcosis: long-term follow-up observation of 20 cases. Transactions of the Royal Society of Tropical Medicine and Hygiene, 103, 768–778. [CrossRef] [PubMed] [Google Scholar]
  36. Matsumoto J, Müller N, Hemphill A, Oku Y, Kamiya M, Gottstein B. 2006. 14–3-3- and II/3-10-gene expression as molecular markers to address viability and growth activity of Echinococcus multilocularis metacestode. Parasitology, 132, 83–94. [CrossRef] [PubMed] [Google Scholar]
  37. Mejri N, Mueller J, Gottstein B. 2011. Intraperitoneal murine Echinococcus multilocularis infection induces differentiation of TGF-β expressing DCs that remain immature. Parasite Immunology, 33, 471–482. [CrossRef] [PubMed] [Google Scholar]
  38. Nakao M, McManus DP, Schantz PM, Craig PS, Ito A. 2007. A molecular phylogeny of the genus Echinococcus inferred from complete mitochondrial genomes. Parasitology, 134, 713–722. [CrossRef] [PubMed] [Google Scholar]
  39. Piarroux M, Piarroux R, Giorgi R, Knapp J, Bardonnet K, Sudre B, Watelet J, Dumortier J, Gérard A, Beytout J, Abergel A, Mantion G, Vuitton DA, Bresson-Hadni S. 2013. Populations at risk for alveolar echinococcosis, France. Emerging Infectious Diseases, 19, 721–728. [CrossRef] [PubMed] [Google Scholar]
  40. Piccoli L, Meroni V, Genco F, Tamarozzi F, Tinelli C, Filice C, Brunetti E. 2012. Serum cytokine profile by ELISA in patients with echinococcal cysts of the liver: a stage-specific approach to assess their biological activity. Clinical and Developmental Immunology, 2012, 483935. [CrossRef] [Google Scholar]
  41. Porot C, Wang J, Germain S, Seimbille Y, Camporese D, Knapp J, Vuitton DA, Blagosklonov O, Gottstein B. 2013. In vitro and in vivo investigations to develop functional imaging by Positron Emission Tomography (PET) for murine and human alveolar echinococcosis, Abstract book, 24th WAAVP Meeting, Perth, Australia. [Google Scholar]
  42. Porot C, Knapp J, Wang J, Camporese D, Germain S, Seimbille Y, Vuitton DA, Gottstein B, Blagosklonov O. 2014. Development of a Specific tracer for alveolar echinococcosis metabolic imaging: a preclinical study. Proc. IEEE Eng. Med. Biol. Soc. (in press). [Google Scholar]
  43. Reuter S, Schirrmeister H, Kratzer W, Dreweck C, Reske SN, Kern P. 1999. Pericystic metabolic activity in alveolar echinococcosis: assessment and follow-up by positron emission tomography. Clinical Infectious Diseases, 29, 1157–1163. [CrossRef] [Google Scholar]
  44. Reuter S, Nüssle K, Kolokythas O, Haug U, Rieber A, Kern P, Kratzer W. 2001. Alveolar liver echinococcosis: a comparative study of three imaging techniques. Infection, 29, 119–125. [CrossRef] [PubMed] [Google Scholar]
  45. Reuter S, Buck A, Manfras B, Kratzer W, Seitz HM, Darge K, Reske SN, Kern P. 2004. Structured treatment interruption in patients with alveolar echinococcosis. Hepatology, 39, 509–517. [CrossRef] [PubMed] [Google Scholar]
  46. Riganò R, Profumo E, Buttari B, Teggi A, Siracusano A. 1999. Cytokine gene expression in peripheral blood mononuclear cells (PBMC) from patients with pharmacologically treated cystic echinococcosis. Clinical and Experimental Immunology, 118, 95–101. [CrossRef] [PubMed] [Google Scholar]
  47. Rogan MT, Hai WY, Richardson R, Zeyhle E, Craig PS. 2006. Hydatid cysts: Does every picture tell a story? Trends in Parasitology, 22, 431–438. [CrossRef] [PubMed] [Google Scholar]
  48. Rouhani S, Parvizi P, Spotin A. 2013. Using specific synthetic peptide (p176) derived AgB 8/1-kDa accompanied by modified patient’s sera: a novel hypothesis to follow-up of Cystic echinococcosis after surgery. Medical Hypotheses, 81, 557–560. [CrossRef] [PubMed] [Google Scholar]
  49. Said-Ali Z, Grenouillet F, Knapp J, Bresson-Hadni S, Vuitton DA, Raoul F, Richou C, Millon L, Giraudoux P, Francechino Network. 2013. Detecting nested clusters of human alveolar echinococcosis. Parasitology, 140, 1693–1700. [CrossRef] [PubMed] [Google Scholar]
  50. Sailer M, Soelder B, Allerberger F, Zaknun D, Feichtinger H, Gottstein B. 1997. Alveolar echinococcosis of the liver in a six-year-old girl with acquired immunodeficiency syndrome. Journal of Pediatrics, 130, 320–323. [CrossRef] [Google Scholar]
  51. Schweiger A, Ammann RW, Candinas D, Clavien PA, Eckert J, Gottstein B, Halkic N, Muellhaupt B, Prinz BM, Reichen J, Tarr PE, Torgerson PR, Deplazes P. 2007. Human alveolar echinococcosis after fox population increase, Switzerland. Emerging Infectious Diseases, 13, 878–882. [CrossRef] [PubMed] [Google Scholar]
  52. Siles-Lucas S, Gottstein B. 2001. Review: molecular tools for the diagnosis of cystic and alveolar echinococcosis. Tropical Medicine and International Health, 6, 463–475. [CrossRef] [Google Scholar]
  53. Siracusano A, Delunardo F, Teggi A, Ortona E. 2012. Host-Parasite relationship in cystic echinococcosis: an evolving story. Clinical and Developmental Immunology, Article ID: 639362. [Google Scholar]
  54. Stojkovic M, Gottstein B, Junghanns T. 2014. Echinococcosis, in Manson’s Tropical Diseases, 23rd edn., Farrar J, Hotez PJ, Junghanss T, Kang G, Lalloo D, White N, Editors. Elsevier Saunders: Amsterdam. p. 795–819. [CrossRef] [Google Scholar]
  55. Stumpe KD, Renner-Schneiter EC, Kuenzle AK, Grimm F, Kadry Z, Clavien PA, Deplazes P, von Schulthess GK, Muellhaupt B, Ammann RW, Renner EL. 2007. F-18-fluorodeoxyglucose (FDG) positron-emission tomography of Echinococcus multilocularis liver lesions: prospective evaluation of its value for diagnosis and follow-up during benzimidazole therapy. Infection, 35, 11–18. [CrossRef] [PubMed] [Google Scholar]
  56. Tappe D, Sako Y, Itoh S, Frosch M, Grüner B, Kern P, Ito A. 2010. Immunoglobulin G subclass responses to recombinant Em18 in the follow-up of patients with alveolar echinococcosis in different clinical stages. Clinical Vaccine Immunology, 17, 944–948. [CrossRef] [Google Scholar]
  57. Torgerson PR, Schweiger A, Deplazes P, Pohar M, Reichen J, Ammann RW, Tarr PE, Halkik N, Müllhaupt B. 2008. Alveolar echinococcosis: from a deadly disease to a well-controlled infection. Relative survival and economic analysis in Switzerland over the last 35 years. Journal of Hepatology, 49, 72. [CrossRef] [PubMed] [Google Scholar]
  58. Torgerson PR. 2003. Economic effects of echinococcosis. Acta Tropica, 85, 113–118. [CrossRef] [PubMed] [Google Scholar]
  59. Vuitton DA, Bresson-Hadni S. 2014. Alveolar echinococcosis: evaluation of the therapeutic strategies. Expert Opinion on Orphan Drugs, 2, 67–86. [CrossRef] [Google Scholar]
  60. Vuitton DA, Gottstein B. 2010. Echinococcus multilocularis and its intermediate host: a model of parasite-host interplay. Journal of Biomedicine and Biotechnology, 2010, 923193. [Google Scholar]
  61. Vuitton D, Zhang SL, Yang Y, Godot V, Beurton I, Mantion G, Bresson-Hadni S. 2006. Survival strategy of Echinococcus multilocularis in the human host. Parasitology International, Suppl., 55, S51–S55. [CrossRef] [PubMed] [Google Scholar]
  62. Wang L, Wen H, Feng X, Jiang X, Duan X. 2012. Analysis of economic burden for patients with cystic echinococcosis in five hospitals in northwest China. Transactions of the Royal Society of Tropical Medicine and Hygiene, 106, 743–748. [CrossRef] [PubMed] [Google Scholar]
  63. Wang J, Lin R, Zhang W, Li L, Gottstein B, Blagosklonov O, Lü G, Zhang C, Lu X, Vuitton DA, Wen H. 2014. Transcriptional profiles of cytokine/chemokine factors of immune cell-homing to the parasitic lesions: a comprehensive one-year course study in the liver of E. multilocularis-infected mice. PLoS One, 9, e91638. [CrossRef] [PubMed] [Google Scholar]
  64. Wang J, Vuitton DA, Müller N, Blagosklonov O, Grandgirard D, Leib SL, Shalev I, Levy G, Lu X, Lin R, Wen H, Spiliotis M, Gottstein B. submitted. Deletion of fibrinogen-like protein 2 (FGL-2), a novel CD4+ CD25+ Treg effector molecule, leads to improved control of Echinococcus mutilocularis infection. European Journal of Immunology. [Google Scholar]
  65. Yamasaki H, Nakaya K, Nakao M, Sako Y, Ito Akira. 2007. Significance of molecular diagnosis using histopathological specimens in cestode zoonoses. Tropical Medicine and Health, 35, 307–321. [CrossRef] [Google Scholar]
  66. Zhang W, Li L, McManus DP. 2003. Concepts in immunology and diagnosis of hydatid disease. Clinical Microbiology Review, 16, 16–36. [Google Scholar]
  67. Zhang W, Wen H, Li J, Lin R, McManus DP. 2012. Immunology and immunodiagnosis of cystic echinococcosis: an update. Clinical and Developmental Immunology, Article ID: 101895, doi: 10.1155/2012/101895. [Google Scholar]
  68. Zhang S, Hüe S, Sène D, Penfornis A, Bresson-Hadni S, Kantelip B, Caillat-Zucman S, Vuitton DA. 2008. Expression of major histocompatibility complex class I chain-related molecule A, NKG2D, and transforming growth factor-beta in the liver of humans with alveolar echinococcosis: new actors in the tolerance to parasites? Journal of Infectious Diseases, 197, 1341–1349. [CrossRef] [Google Scholar]
  69. Zingg W, Renner-Schneiter EC, Pauli-Magnus C, Renner EL, van Overbeck J, Schläpfer E, Weber M, Weber R, Opravil M, Gottstein B, Speck RF, the Swiss HIV Cohort Study. 2004. Alveolar echinococcosis of the liver in an adult with human immunodeficiency virus type-1 infection. Infection, 32, 299–302. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.